HCA Healthcare ( NYSE:HCA – Get Rating ) had its price objective raised by Truist Financial from $325.00 to $340.00 in a research report sent to investors on Tuesday morning, The Fly reports. A number of other analysts also recently commented on the company. Stephens reiterated an overweight rating and set a $283.00 target price on shares of HCA Healthcare in a research report on Friday, April 21st. Deutsche Bank Aktiengesellschaft upped their price target on shares of HCA Healthcare from $280.

https://www.dailypolitical.com/2023/06/24/hca-healthcare-nysehca-price-target-raised-to-340-00-at-truist-financial.html

#dailypolitical